Search form

Joseph Lazzarotti Discusses Implications of New Digital Tracking Pill Approved by FDA

Joseph Lazzarotti discusses data security and patient consent concerns surrounding the first FDA approved digital pill in "New digital pill raises consent, data security issues," published by BenefitsPRO.com.

Subscription may be required to view article

Mentioned

People

See AllRelated News

July 9, 2018
EVERFI

Jason Gavejian, Joseph Lazzarotti and Mary Costigan Discuss Successful Compliance With GDPR

July 9, 2018

Jason Gavejian, Joseph Lazzarotti and Mary Costigan discuss steps for businesses to take in the age of GDPR in "How the GDPR gives new meaning to established privacy and security principles," published by EVERFI. Subscription may be required to view article Read More

June 18, 2018
TechTarget

Gregory Alvarez and Victor Barkalov Discuss Jackson Lewis' Commitment to Technology-Enabled Transformation

June 18, 2018

Gregory Alvarez and Victor Barkalov discuss the firm's strategic plan to provide clients with leading-edge technologies via self-service apps, automated data-driven compliance assessments, artificial intelligence and soon, chatbots, in "Law firm makes case for technology-enabled transformation,"... Read More

November 3, 2017
Law 360

Lisa Marrello Discusses Anoush Koroghlian-Scott Joining Jackson Lewis

November 3, 2017

Lisa Marrello discusses Anoush Koroghlian-Scott recently joining Jackson Lewis, focusing her practice on health care and data security in "Health Hires: Jackson Lewis, EBG, Spencer Fane, AMRI," published by Law360. Subscription may be required to view article Read More